Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 ⁺ T Cells

Fiorenza Cocchi, Anthony L. DeVico, Alfredo Garzino‐Demo et al. · Science · 1995 · 2.9K citations

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations · Full text

Standard Deviations, Immunology, Pharmacotherapy +19

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

Lut Van Damme, Gita Ramjee, Michel Alary et al. · The Lancet · 2002 · 795 citations

Female Sex Workers, Sexual Health, Contraception +10

The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

Christopher N. Scanlan, Ralph Pantophlet, Mark R. Wormald et al. · Journal of Virology · 2002 · 662 citations · Full text

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

Michael R. Boyd, Kirk R. Gustafson, James B. McMahon et al. · Antimicrobial Agents and Chemotherapy · 1997 · 607 citations · Full text

Viral Replication, Immunology, Escherichia Coli +17